Quant Mid Cap Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 07-04-2020

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the scheme is to seek to generate capital appreciation & provide longterm growth opportunities by investing in a portfolio of Mid Cap companies. There is no assurance that the investment objective of the Scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Quant Mid Cap Fund-Growth -23.58 -23.48 -26.35 -4.24 -1.40 7.86
Nifty Midcap 150 -25.65 -27.63 -29.80 N/A N/A -13.31

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Quant Mid Cap Fund-Growth Feb 26, 2001 Unrated -26.35 -4.24 -1.40 2.48 10.39
HDFC MID-CAP OPPORTUNITIES FUND - Growth Option Jun 25, 2007 -32.89 -9.19 0.14 1.79 22,754.65
Franklin India Prima Fund-Growth Dec 01, 1993 -31.14 -8.43 -0.27 1.88 7,475.49
DSP Midcap Fund - Regular Plan - Growth Nov 14, 2006 -21.50 -4.92 3.11 1.93 7,458.11
Nippon India Growth Fund-Growth Plan-Growth Option Oct 08, 1995 -28.10 -6.20 -0.18 2.07 7,153.80
Kotak Emerging Equity Scheme - Growth Mar 30, 2007 -26.67 -7.05 1.55 1.88 6,848.32

Fund Holdings as on 29-February-2020

  • Godrej Agrovet Ltd.

  • Credit Access Grameen Ltd.

  • Reliance Nippon Life Asset Management

  • Bandhan Bank Ltd.

  • Cadila Healthcare Ltd.

  • Tata Consultancy Services Ltd.

  • Manappuram Finance Ltd.

  • Alembic Pharmaceuticals Ltd.

  • SANOFI INDIA Ltd.

  • Glaxosmithkline Pharmaceuticals Ltd.

  • Pfizer Ltd.

  • GMR Infrastructure Ltd.

  • Hindustan Unilever Ltd.

  • Abbott India Ltd.

  • DLF Ltd.

  • a) Other Receivables (Payables)

  • Dalmia Bharat Ltd.

  • Petronet LNG Ltd.

  • Bayer Cropscience Ltd.

  • Info Edge (India) Ltd.

  • Biocon Ltd.

  • Godrej Consumer Products Ltd.

  • SBI Life Insurance Company Ltd.

  • PI Industries Ltd.

  • Sundaram Finance Ltd.

  • Arti Surfactants Ltd.

View More
  • Pharmaceuticals & Drugs

  • Finance - NBFC

  • Consumer Food

  • Finance - Asset Management

  • Bank - Private

  • IT - Software

  • Household & Personal Products

  • Engineering - Construction

  • Pesticides & Agrochemicals

  • Construction - Real Estate

  • Miscellaneous

  • Cement & Construction Materials

  • Industrial Gases & Fuels

  • BPO/ITeS

  • Insurance

  • Unspecified

View More

About Quant Mid Cap Fund

Scheme Analysis

Quant Mid Cap Fund is a Equity - Mid Cap Fund fund and belongs to Quant Mutual Fund. It was launched on 26-Feb-2001 and currently has an AUM of ₹10.39 crore. Quant Mid Cap Fund is benchmarked against Nifty Midcap 150 as primary index.

The NAV of Quant Mid Cap Fund ended up ₹2.98(7.02%)yesterday to ₹45.4802.

Among its top 3 holdings the fund has exposure to Godrej Agrovet Ltd., and

The Quant Mid Cap Fund is managed by Sanjeev Sharma and Vasav Sahgal.

Fund House Contact

11, Scindia House, Connaught Circus, New Delhi - 110 001

011-43587415, 43587420
help@quant.in
011-43587432

Fund Manager

  • Cash

  • Equity

View More